Cargando…
Functional Characterization of the spf/ash Splicing Variation in OTC Deficiency of Mice and Man
The spf/ash mouse model of ornithine transcarbamylase (OTC) deficiency, a severe urea cycle disorder, is caused by a mutation (c.386G>A; p.R129H) in the last nucleotide of exon 4 of the Otc gene, affecting the 5’ splice site and resulting in partial use of a cryptic splice site 48 bp into the adj...
Autores principales: | Rivera-Barahona, Ana, Sánchez-Alcudia, Rocío, Viecelli, Hiu Man, Rüfenacht, Veronique, Pérez, Belén, Ugarte, Magdalena, Häberle, Johannes, Thöny, Beat, Desviat, Lourdes Ruiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390381/ https://www.ncbi.nlm.nih.gov/pubmed/25853564 http://dx.doi.org/10.1371/journal.pone.0122966 |
Ejemplares similares
-
Correction: Functional Characterization of the spf/ash Splicing Variation in OTC Deficiency of Mice and Man
por: Rivera-Barahona, Ana, et al.
Publicado: (2015) -
A Sensitive Assay System To Test Antisense Oligonucleotides for Splice Suppression Therapy in the Mouse Liver
por: Gallego-Villar, Lorena, et al.
Publicado: (2014) -
Sustained Correction of OTC Deficiency in Spf (ash) mice Using Optimized Self-complementary AAV2/8 Vectors
por: Wang, Lili, et al.
Publicado: (2011) -
OTC intron 4 variations mediate pathogenic splicing patterns caused by the c.386G>A mutation in humans and spf(ash) mice, and govern susceptibility to RNA-based therapies
por: Sacchetto, Claudia, et al.
Publicado: (2021) -
An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective spf/ash Mouse Model of Ornithine Transcarbamylase Deficiency
por: Balestra, Dario, et al.
Publicado: (2020)